insights_auto
Outlook: 55.6% bullish·0.0% bearish
Go to analysischevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ ३१.७६
arrow_upward
+१.२१%(+०.३८) 1D
US$ ३१.७६
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर १०, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ ३१.००
High
US$ ३१.८९
Low
US$ ३०.४८
Mkt. cap
१.९० अरब
Avg. vol.
१२.९३ लाख
Volume
१०.०५ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ ३१.००
High
US$ ३१.८९
Low
US$ ३०.४८
Mkt. cap
१.९० अरब
Avg. vol.
१२.९३ लाख
Volume
१०.०५ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ६.३२
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
Yahoo Finance
·
१ घण्टा पहिले
Why this top Wall Street strategist isn't bullish on the S&P 500 for 2027
Investor's Business Daily
·
१ घण्टा पहिले
Dow Jones Futures: Stock Market Falls On Surging Treasury Yields, Nvidia Sell-Off; CoreWeave Rises Late
Investing.com
·
५४ मिनेट पहिले
American Barrick files for NYSE IPO as controlled unit of parent Barrick Mining
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc